活体基因编辑和细胞疗法治疗遗传性铁血病1型
Ilayda Ates1, Callie Stuart1, Tanner Rathbone1
1Department of Bioengineering, Clemson University, Clemson, South Carolina, USA.
Hepatology communications
|April 26, 2024
概括
这项研究开发了一种使用CRISPR-Cas9和细胞疗法的ex vivo基因编辑协议,用于治疗小鼠1型遗传性铁血病 (HT1). 优化的方法成功地纠正了小鼠的疾病指标,证明了对HT1.1的潜在治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因治疗 基因治疗
- 这就是CRISPR技术.
背景情况:
- 遗传性铁血病1型 (HT1) 是一种遗传性肝脏疾病,由烟乙酸酸酶 (FAH) 缺乏引起.
- 之前的研究表明,在体内进行CRISPR基因编辑以删除4-基酸二氧化酶 (HPD) 以用于小鼠HT1救援.
研究的目的:
- 开发一种ex vivo基因编辑协议,用于1型遗传性铁血病 (HT1).
- 在小鼠模型中,将开发的协议应用于HT1的细胞疗法.
主要方法:
- 从野生型和Fah-/-小鼠中分离出肝细胞.
- 针对HPD的CRISPR-Cas9核糖蛋白通过电穿孔进入肝细胞.
- 基因编辑的肝细胞被化在细胞因子恢复介质中,以防止在接受Fah-/-小鼠的脊髓注射之前发生亡.
主要成果:
- 细胞因子恢复介质对于基因编辑肝细胞的强大移植和扩张至关重要 (46.8%对0.83%).
- 基因编辑的Fah-/-肝细胞的移植导致了显著的移植 (35%的RNP,28%的mRNA).
- 生物化学标记物,包括氨酸和氨酸水平,在接受治疗的小鼠中正常化,表明疾病纠正.
结论:
- 这项研究验证了一种ex vivo基因编辑和细胞治疗方案,用于治疗HT1.
- 与肝细胞移植相结合的电穿孔显示出作为遗传性肝脏疾病治疗策略的前景.
- 这种方法为HT1疾病模型提供了潜在的治疗方法.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
What is Genetic Engineering?
74.1K
Overview
74.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K


